Monoclonal antibody (2.15 antibody) generated using antibody phase technology, is observed to be selectively taken up by mice grafted subcutaneously with MDA-MB-231 human breast cancers cells and its localization matched that of the cell surface p32/HABP1. The gene discussed is C1QBP; the disease is breast carcinoma.